Meta insider Cox unloads $46M in stock; retains 292k shares

Rhea-AI Filing Summary

Meta Platforms (META) – Form 4 filing dated 08/07/2025

Chief Product Officer Christopher K. Cox sold 60,000 Class A shares on 08/05/2025 under a previously adopted Rule 10b5-1 plan (established 05/05/2025). The disposals were executed in six tranches at weighted-average prices ranging from $774.17 to $779.29, generating roughly $46.5 million in gross proceeds.

Following the transactions, Cox’s Revocable Trust directly holds 237,205 shares, while an Irrevocable Remainder Trust holds an additional 55,046 shares, leaving Cox with total beneficial ownership of about 292,251 shares.

No derivative security activity was reported. The sales reduce Cox’s directly held stake by roughly 20% but were conducted pursuant to an automatic trading plan, mitigating concerns over informational advantage.

Positive

• None.

Negative

• 60,000-share insider sale (~$46.5 m) by META’s Chief Product Officer could be interpreted as reduced insider confidence despite 10b5-1 scheduling.

Insights

Securities Analyst

TL;DR: Senior META exec sold 60k shares (~$46.5m) via 10b5-1; modestly negative sentiment but not alarming.

The size of the sale (≈20% of Cox’s trust holdings) is noticeable and may pressure short-term sentiment, especially as META trades near its highs. However, the use of a pre-scheduled 10b5-1 plan adopted three months earlier lessens governance risk. Cox still retains ~292k shares, aligning him with shareholders. Historically, META insiders regularly monetize options without signaling operational deterioration. Impact is therefore moderately negative but not materially so for valuation fundamentals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cox Christopher K

(Last) (First) (Middle)

C/O META PLATFORMS, INC.

1 META WAY

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Meta Platforms, Inc. [ META ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/05/2025		S(1)		4,040	D	$774.1657(2)	293,165	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/05/2025		S(1)		22,468	D	$775.2769(4)	270,697	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/05/2025		S(1)		19,012	D	$776.0791(5)	251,685	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/05/2025		S(1)		12,005	D	$777.0797(6)	239,680	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/05/2025		S(1)		1,675	D	$778.1778(7)	238,005	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/05/2025		S(1)		800	D	$779.2931(8)	237,205	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock								55,046	I	Cox-Vadakan Irrevocable Remainder Trust(9)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2025.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $773.67 to $774.64 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $774.675 to $775.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.675 to $776.65 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.68 to $777.6401 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.70 to $778.59 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.14 to $779.44 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

9. Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.

	/s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many META shares did Christopher K. Cox sell on 08/05/2025?

He disposed of 60,000 Class A shares in six separate tranches.

What was the average sale price for the insider transaction?

Weighted-average prices ranged from $774.17 to $779.29 per share.

Was the sale conducted under a Rule 10b5-1 trading plan?

Yes, the plan was adopted on 05/05/2025, providing an affirmative defense against insider-trading accusations.

How many META shares does Cox still beneficially own after the sale?

He retains 237,205 shares in his Revocable Trust plus 55,046 shares in an Irrevocable Trust.

Did the Form 4 report any option exercises or derivative security activity?

No. Table II shows no derivative transactions for the period.